MRA Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,762
| Closed | -$247K | – | 155 |
|
|
2025
Q1 | $247K | Sell |
9,762
-5,438
| -36% | -$138K | 0.13% | 100 |
|
|
2024
Q4 | $403K | Sell |
15,200
-6,940
| -31% | -$184K | 0.21% | 57 |
|
|
2024
Q3 | $641K | Sell |
22,140
-140
| -0.6% | -$4.05K | 0.35% | 37 |
|
|
2024
Q2 | $623K | Buy |
22,280
+3,970
| +22% | +$111K | 0.36% | 34 |
|
|
2024
Q1 | $508K | Buy |
18,310
+2,132
| +13% | +$59.2K | 0.3% | 46 |
|
|
2023
Q4 | $466K | Sell |
16,178
-639
| -4% | -$18.4K | 0.31% | 48 |
|
|
2023
Q3 | $558K | Sell |
16,817
-3,024
| -15% | -$100K | 0.4% | 51 |
|
|
2023
Q2 | $728K | Buy |
19,841
+461
| +2% | +$16.9K | 0.5% | 35 |
|
|
2023
Q1 | $791K | Buy |
19,380
+2,697
| +16% | +$110K | 0.57% | 31 |
|
|
2022
Q4 | $855K | Buy |
16,683
+476
| +3% | +$24.4K | 0.67% | 31 |
|
|
2022
Q3 | $677K | Buy |
16,207
+141
| +0.9% | +$5.89K | 0.58% | 33 |
|
|
2022
Q2 | $842K | Sell |
16,066
-4,314
| -21% | -$226K | 0.74% | 27 |
|
|
2022
Q1 | $1.06M | Buy |
20,380
+1,151
| +6% | +$59.6K | 0.8% | 26 |
|
|
2021
Q4 | $1.14M | Sell |
19,229
-242
| -1% | -$14.3K | 0.88% | 29 |
|
|
2021
Q3 | $837K | Buy |
19,471
+596
| +3% | +$25.6K | 0.71% | 34 |
|
|
2021
Q2 | $739K | Buy |
18,875
+1,656
| +10% | +$64.8K | 0.63% | 37 |
|
|
2021
Q1 | $624K | Buy |
17,219
+606
| +4% | +$22K | 0.59% | 41 |
|
|
2020
Q4 | $612K | Buy |
+16,613
| New | +$612K | 0.6% | 40 |
|